SBC Medical Group Holdings (SBC) Current Deferred Revenue (2023 - 2025)

SBC Medical Group Holdings has reported Current Deferred Revenue for 3 years, with the latest figure at $1.4 million in Q4 2025.

• For the quarter ending Q4 2025, Current Deferred Revenue fell 87.94% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (down 87.94% YoY), and the FY2025 full-year result was $1.4 million, down 87.94% from the prior year.
• Current Deferred Revenue for Q4 2025 stood at $1.4 million, up from $1.0 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $23.1 million in Q4 2023, with the low at $565495.0 in Q3 2024.
• Historically, Current Deferred Revenue has averaged $8.3 million across 3 years, with a median of $10.2 million in 2025.
• The largest YoY upside for Current Deferred Revenue was 82.21% in 2025 against a maximum downside of 87.94% in 2025.
• SBC Medical Group Holdings' Current Deferred Revenue stood at $23.1 million in 2023, then sank by 49.09% to $11.7 million in 2024, then slumped by 87.94% to $1.4 million in 2025.
• The last three Current Deferred Revenue figures came in at $1.4 million (Q4 2025), $1.0 million (Q3 2025), and $10.3 million (Q2 2025), per Business Quant data.